Light physical activity may help lower death risk in cardiovascular-kidney-metabolic syndrome, a condition that includes ...
Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback